Similar articles for PMID: 27069631

Year	Number of Results
2001	1
2003	2
2005	2
2006	1
2007	6
2008	4
2009	3
2010	4
2012	2
2013	4
2014	3
2015	3
2016	5
2017	5
2018	10
2019	14
2020	8
2021	3
2024	0

1

Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome.

Rubio M, Valdeolivas S, Piscitelli F, Verde R, Satta V, Barroso E, Montolio M, Aras LM, Di Marzo V, Sagredo O, Fernández-Ruiz J. Rubio M, et al. Pharmacol Res Perspect. 2016 Mar 5;4(2):e00220. doi: 10.1002/prp2.220. eCollection 2016 Apr. Pharmacol Res Perspect. 2016. PMID: 27069631 Free PMC article.

2

Molecular Targets of Cannabidiol in Neurological Disorders.

Ibeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ. Ibeas Bih C, et al. Neurotherapeutics. 2015 Oct;12(4):699-730. doi: 10.1007/s13311-015-0377-3. Neurotherapeutics. 2015. PMID: 26264914 Free PMC article. Review.

3

Cannabis for the Treatment of Epilepsy: an Update.

Gaston TE, Szaflarski JP. Gaston TE, et al. Curr Neurol Neurosci Rep. 2018 Sep 8;18(11):73. doi: 10.1007/s11910-018-0882-y. Curr Neurol Neurosci Rep. 2018. PMID: 30194563 Review.

4

Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.

Ryan D, Drysdale AJ, Pertwee RG, Platt B. Ryan D, et al. Eur J Neurosci. 2007 Apr;25(7):2093-102. doi: 10.1111/j.1460-9568.2007.05448.x. Eur J Neurosci. 2007. PMID: 17419758

5

Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.

Kaplan JS, Stella N, Catterall WA, Westenbroek RE. Kaplan JS, et al. Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11229-11234. doi: 10.1073/pnas.1711351114. Epub 2017 Oct 2. Proc Natl Acad Sci U S A. 2017. PMID: 28973916 Free PMC article.

6

Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes.

Chen JW, Borgelt LM, Blackmer AB. Chen JW, et al. Ann Pharmacother. 2019 Jun;53(6):603-611. doi: 10.1177/1060028018822124. Epub 2019 Jan 8. Ann Pharmacother. 2019. PMID: 30616356 Review.

7

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects.

Morano A, Fanella M, Albini M, Cifelli P, Palma E, Giallonardo AT, Di Bonaventura C. Morano A, et al. Neuropsychiatr Dis Treat. 2020 Feb 7;16:381-396. doi: 10.2147/NDT.S203782. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32103958 Free PMC article. Review.

8

Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy.

Franco V, Perucca E. Franco V, et al. Drugs. 2019 Sep;79(13):1435-1454. doi: 10.1007/s40265-019-01171-4. Drugs. 2019. PMID: 31372958 Review.

9

Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.

Laux LC, Bebin EM, Checketts D, Chez M, Flamini R, Marsh ED, Miller I, Nichol K, Park Y, Segal E, Seltzer L, Szaflarski JP, Thiele EA, Weinstock A; CBD EAP study group. Laux LC, et al. Epilepsy Res. 2019 Aug;154:13-20. doi: 10.1016/j.eplepsyres.2019.03.015. Epub 2019 Mar 25. Epilepsy Res. 2019. PMID: 31022635 Free article. Clinical Trial.

10

Endocannabinoid System: A Multi-Facet Therapeutic Target.

Kaur R, Ambwani SR, Singh S. Kaur R, et al. Curr Clin Pharmacol. 2016;11(2):110-7. doi: 10.2174/1574884711666160418105339. Curr Clin Pharmacol. 2016. PMID: 27086601 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

74 results

Results by year